Here, we perform a two-sample MR analysis to test the hypothesis that genetically determined CRP and fibrinogen and their upstream inflammatory biomarkers, IL-1 and IL-6, are associated with HF risk in a European population. The gene discussed is IL1B; the disease is hydrops fetalis.